Navigation Links
deCODE genetics Announces Second Quarter 2008 Financial Results
Date:8/6/2008

(4,120) (3,803) (8,145) (7,469)

Other non-operating income

and (expense), net* (1,170) 8,922 (5,247) 8,542

Net loss $ (18,354) $ (16,228) $ (45,019) $ (38,853)

Basic and diluted net loss

per share: $ (0.30) $ (0.27) $ (0.73) $ (0.64)

Shares used in computing

basic and diluted net loss

per share 61,371 61,005 61,318 60,977

Condensed Consolidated Balance Sheet Data

At June 30, At December 31,

2008 2007

in thousands (unaudited)

Cash and investments** $ 49,433 $ 94,058

Total assets 110,617 156,208

Total liabilities 297,446 301,858

Total shareholders' equity (186,829) (145,650)

* Other non-operating expense for the three and six months ended June 30, 2008 principally reflect an unrealized loss resulting from the revaluation of the company's non-current auction rate security investments as of June 30, 2008.

** Cash and investments include cash equivalents, restricted cash equivalents, current and non-current investments.

Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events, to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relations
'/>"/>

SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
2. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results
3. deCODE genetics Announces Third Quarter 2007 Financial Results
4. deCODE Launches deCODEme(TM)
5. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
6. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
7. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
8. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
9. deCODE Genetics Announces Full-year 2007 Financial Results
10. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
11. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, ... today announced positive topline safety and tolerability ... of SYN-004, the Company,s investigational oral beta-lactamase ... difficile (C. difficile) infection, antibiotic-associated diarrhea ...
(Date:12/22/2014)... CHAPEL HILL, N.C. , Dec. 22, 2014 ... ALNE) today announced that it has signed a ... biotechnology company that has developed and patented a ... and medical diagnostics products that enable rapid on-site ... and alcohol use/abuse and health issues in an ...
(Date:12/22/2014)... Calif. , Dec. 22, 2014  ( www.competitivehealth.com ... CoPatient, an online medical bill review and advocacy service, ... in the FREE WellCard Savings discount health services marketplace. ... bill that was more than they expected to pay. ... reduce health care costs, WellCard Savings is pleased to ...
(Date:12/22/2014)... 2014 ITRA Global, one of the ... commercial real estate, has further expanded its global reach ... and Brisbane, Western Australia, reports Mylinda Vick, CCIM, Chairman ... ITRA Global / ACORPP (Australian Corporate Property and Projects) ... providing property services to a wide range of clients ...
Breaking Biology Technology:Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5ALNE Announces Intention To Acquire BioTechPharma 2WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2
... ROCKVILLE, Md., Nov. 26 Human Genome,Sciences, Inc. (Nasdaq: ... the,Piper Jaffray 19th Annual Health Care Conference will be ... (Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO ), A member of ... of the company on Wednesday, November 28, 2007 at ...
... Genta,Incorporated (Nasdaq: GNTA ) announced today ... Raymond P. Warrell, Jr., will provide a,company overview ... Capital,Markets 4th Annual Healthcare Conference. Genta,s presentation is ... at the New York Palace Hotel,New York, NY., ...
... Orthopedic Surgeons and Rheumatologists Performing More Procedures, ... US,Hyaluronic Acid (HA) Viscosupplementation Marketrack(TM) service, which,captures data ... groups provided more HA knee injections in Q3 ... in both groups, there are substantial,differences in the ...
Cached Biology Technology:Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference 2Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference 3Hyaluronic Acid Knee Procedures Grow 38% from Q3 2006 to Q3 2007 2
(Date:12/5/2014)... -- Tute Genomics, a leader in cloud-based solutions for genome ... led by UK-based Eurovestech. Peak Ventures and a number ... "We are at a pivotal time in ... seeks new approaches for the diagnosis, treatment and prevention ... and CEO of Tute Genomics. "One of the main ...
(Date:12/3/2014)... Calif. , Dec. 2, 2014   ... globally deployed, innovative test solutions for military, aerospace, ... newest version of its successful TS-900 PXI ... performance and features of high-end systems to customers ... outstanding value compared to traditional ATE. ...
(Date:11/21/2014)... According to a new market ... RFID, Access Control, Intrusion Detection, Parking Management, Under Vehicle ... Service Geography - Global Forecasts to 2020", published by ... be around $25 Billion in 2014 and is expected ... CAGR of 8.69%. Browse 116 market data ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... Lithosphere is now online. Locations studied include the ... Wet Mountains of Central Colorado, USA; the Basgo ... Utah, USA; Knight Inlet in the southwestern Coast ... shear zones in the western Canadian Shield of ...
... Genetic tests can now tell us whether we are ... asthma and a number of other conditions., Other genetic tests ... be harmed by side effects linked to your genetic code. ... illnesses in others will require that doctors have access to ...
... The forage grasses and other plants beef cattle ... University animal science researchers report that steers grazing on one ... growth, carcass and meat quality. The research can help ... are looking to add weight and value to their animals ...
Cached Biology News:Lithosphere interprets earth 2Lithosphere interprets earth 3Lithosphere interprets earth 4Lithosphere interprets earth 5Lithosphere interprets earth 6Lithosphere interprets earth 7Genetics in Medicine publishes special issue dedicated to genomics in electronic health records 2Genetics in Medicine publishes special issue dedicated to genomics in electronic health records 3Genetics in Medicine publishes special issue dedicated to genomics in electronic health records 4
MOUSE ANTI HUMAN C-MYC aa171-188...
RABBIT ANTI NEOPTERIN...
... • Beagle serum is collected from fasted ... of age Available Anticoagulants: N-02: ... N-06: K2EDTA N-08: Potassium Oxalate ... Alsevers N-05: ACD N-07: ...
Collected from normal, healthy animals in carefully maintained standing herds of US orgin. Pricing: $45/unit for 1 - 10 units...
Biology Products: